Stockscreener 앱 받기
0.4028
7.27%
-0.0316
전일 마감가:
$0.4344
열려 있는:
$0.431
하루 거래량:
320.84K
Relative Volume:
0.27
시가총액:
$5.36M
수익:
$72,100
순이익/손실:
$-3.60M
주가수익비율:
-0.3385
EPS:
-1.19
순현금흐름:
$-3.37M
1주 성능:
-11.36%
1개월 성능:
-2.52%
6개월 성능:
-31.43%
1년 성능:
-51.77%
1일 변동 폭
$0.4028
$0.4373
1주일 범위
$0.4028
$0.4599
52주 변동 폭
$0.3601
$3.3699
Silo Pharma Inc Stock (SILO) Company Profile
명칭
Silo Pharma Inc
전화
(718) 400-9031
주소
677 N. WASHINGTON BLVD, SARASOTA
SILO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.49 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.17 | 303.77M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
5.04 | 221.34M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.67 | 0 | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
46.76 | 0 | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc 주식(SILO)의 최신 뉴스
What drives Silo Pharma Inc stock priceGrowth vs. Value Investing & Download Our Free Trading Blueprint - earlytimes.in
Silo Pharma (NASDAQ:SILO) Stock Price Down 2.8% – What’s Next? - Defense World
How Silo Pharma Inc. stock performs during Fed tightening cycles2025 Top Decliners & Community Verified Trade Alerts - Newser
SILO Pharma (SILO) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Silo Pharma Inc. stock remains resilientJuly 2025 Spike Watch & Safe Capital Preservation Plans - BỘ NỘI VỤ
Is Silo Pharma Inc a good long term investmentContrarian Investment Ideas & Free Record-Breaking Gains - earlytimes.in
Silo Pharma CEO Weisblum buys $735 in company stock By Investing.com - Investing.com Australia
Silo Pharma CEO Weisblum buys $735 in company stock - Investing.com India
[Form 4] Silo Pharma, Inc. Insider Trading Activity - Stock Titan
Will earnings trigger a reversal in Silo Pharma Inc.Market Risk Report & Smart Investment Allocation Tips - newser.com
Is Silo Pharma Inc. stock attractive for long term wealth buildingEntry Point & Long-Term Safe Return Strategies - newser.com
Is now a turning point for Silo Pharma Inc.July 2025 Analyst Calls & Accurate Intraday Trade Tips - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission By Investing.com - Investing.com Nigeria
Evaluating Silo Pharma Inc. with trendline analysisMarket Rally & Weekly Stock Performance Updates - newser.com
Silo Pharma selects Allucent to support PTSD treatment IND submission - Investing.com
Silo Pharma partners with Allucent to support planned FDA Investigational New Drug application for SPC-15 as a therapeutic for PTSD - MarketScreener
Silo Pharma Partners With Allucent To Support Planned FDA Investigational New Drug Application For Spc-15 As A Therapeutic For Ptsd - TradingView
Silo Pharma Partners with Allucent to Support Planned FDA - GlobeNewswire
Silo Pharma (Nasdaq: SILO) taps Allucent to advance SPC-15 PTSD intranasal IND prep - Stock Titan
Can Silo Pharma Inc. stock deliver strong Q4 earningsNew Guidance & Free Safe Entry Trade Signal Reports - newser.com
Will Silo Pharma Inc. rebound enough to break evenExit Point & Weekly Watchlist for Hot Stocks - newser.com
Combining price and volume data for Silo Pharma Inc.July 2025 Trends & Consistent Profit Trade Alerts - newser.com
[10-Q] Silo Pharma, Inc. Quarterly Earnings Report | SILO SEC FilingForm 10-Q - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
What analysts say about Silo Pharma Inc stockEx-Dividend Date Alerts & Maximize ROI With Proven Growth Stocks - earlytimes.in
How strong is Silo Pharma Inc. stock revenue growthJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Silo Pharma announces pricing of $2 million public offering - MSN
Is Silo Pharma Inc. showing signs of accumulationEarnings Risk Report & Consistent Profit Focused Trading Strategies - newser.com
Silo Pharma Inc (SILO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Silo Pharma Inc 주식 (SILO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Weisblum Eric | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.36 |
1,000 |
365 |
211,932 |
| Weisblum Eric | Chief Executive Officer |
Nov 18 '25 |
Buy |
0.40 |
7,500 |
3,025 |
205,432 |
| Weisblum Eric | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.41 |
4,500 |
1,823 |
209,932 |
| Weisblum Eric | Chief Executive Officer |
May 27 '25 |
Buy |
0.43 |
10,000 |
4,329 |
197,932 |
0.36%
1.12%
자본화:
|
볼륨(24시간):